CN1326737A - External use medicine for curing sexual disease and its preparing process - Google Patents
External use medicine for curing sexual disease and its preparing process Download PDFInfo
- Publication number
- CN1326737A CN1326737A CN 00113827 CN00113827A CN1326737A CN 1326737 A CN1326737 A CN 1326737A CN 00113827 CN00113827 CN 00113827 CN 00113827 A CN00113827 A CN 00113827A CN 1326737 A CN1326737 A CN 1326737A
- Authority
- CN
- China
- Prior art keywords
- std
- medicine
- sexually transmitted
- transmitted disease
- white vaseline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The external use medicine for treating sexual disease is prepared with metronidazole, Clotrimazole, chlorhexidine acetate, fludrocortisone acetate, stillbestrol, borneol, white vaseline and through mixing, crushing, capsulizing, and cream preparation. It can cure radically condyloma accuminatum, gonorrhea, psoriasis and piles without toxic side effect.
Description
The present invention relates to a kind of external used medicine and preparation technology thereof, relate in particular to a kind of external used medicine and preparation technology thereof who treats sexually transmitted disease (STD).
Sexually transmitted disease (STD) such as condyloma acuminatum, gonorrhea is urinary system and the skin diseases that is caused by different viral infection with psoriasis, and its clinical symptoms and serious hazardness are known by people.Condyloma acuminatum and gonorrhea virus are liked settling growth, breeding at the pudendum membrane junction place of warm moist, and the initial stage is light red pimple, increases gradually, becomes huge wart body, and erosion when serious is if obstinate shows effect repeatedly and brings out the genitals canceration easily.At present, condyloma acuminatum in the clinical treatment sexually transmitted disease (STD) adopts laser, freezing, carbonization, operation or simple medication mostly, and these methods treatment condyloma acuminatum have the effect that shadow is seen in vertical rod through clinical confirmation, but just surface symptoms disappears, and fundamentally virus is not thoroughly removed.Secondly, condyloma acuminatum in passive immunization such as application of interference element, the transfer factor treatment sexually transmitted disease (STD), these Therapeutic Method form persistent antibody easily, just suppress virus replication, easily recurrence after the drug withdrawal, and treatment cost height, condyloma acuminatum, gonorrhea and psoriasis in simple western medicine or the treatment by Chinese herbs sexually transmitted disease (STD), prescription is many, complicated process of preparation, the course of treatment is long, and it is slow to take effect, and medical expense is also than higher.
Purpose of the present invention just is to disclose a kind ofly has multiple pharmaceutical compositions combined effect in focus, and can fundamentally eradicate condyloma acuminatum, gonorrhea and psoriatic a kind of external used medicine and preparation technology thereof who treats sexually transmitted disease (STD) in sick.
For achieving the above object, the present invention is made by the following raw materials in part by weight component:
Metronidazole 95-100 clotrimazole 20-25 chlorhexidine acetate 6-8
Fludrocortisone acetate 0.3-0.5 diethylstilbestrol 0.2-0.25 Borneolum Syntheticum 15-17
White vaseline 2700-3000
The optimum weight of medicine of the present invention (part) proportioning is:
Metronidazole 100 clotrimazoles 25 chlorhexidine acetates 7.5
Fludrocortisone acetate 0.5 diethylstilbestrol 0.25 Borneolum Syntheticum 17
White vaseline 3000
The said medicament of the present invention is capsule or cream.
Above-mentioned each component is made medicine production method of the present invention is:
(1) mixes: take by weighing all medicines by composition weight (except the white vaseline), mix;
(2) pulverize: the hybrid medicine processing powder is broken into 100 order fineness;
(3) manufacture capsule: in the hybrid medicine after will pulverizing incapsulates;
(4) manufacture cream: hybrid medicine and white vaseline after will pulverizing are mixed and made into cream.
Advantage of the present invention is: the prescription novelty is unique, raw material is few, and preparation technology is simple, and administration is easy to use, evident in efficacy, and can thoroughly eradicate condyloma acuminatum, gonorrhea and psoriasis in men and women's sexually transmitted disease (STD), no pain, have no side effect, this medicine of tool clinical observation also has good therapeutical effect to hemorrhoid.
Now invention is described in further detail in conjunction with an embodiment:
Take by weighing raw material by following proportioning:
Metronidazole 100Kg clotrimazole 25Kg chlorhexidine acetate 7.5Kg
Fludrocortisone acetate 0.5Kg diethylstilbestrol 0.25Kg Borneolum Syntheticum 17Kg
White vaseline 3000Kg
Its production method is as follows:
(1) mixes: take by weighing all medicines by composition weight (except the white vaseline), mix, stir;
(2) pulverize: the hybrid medicine processing powder is broken into 100 order fineness;
(3) manufacture capsule: in the hybrid medicine after will pulverizing incapsulates by every 0.3 gram;
(4) manufacture cream: hybrid medicine and white vaseline after will pulverizing are mixed and made into cream.
During use, medicament capsule is pushed the purpose that vagina or anal can reach the treatment sexually transmitted disease (STD), only need medicinal frost formulation embrocated at lesions position for supracutaneous sexually transmitted disease (STD) and get final product for the deep sexually transmitted disease (STD).This medicine in use directly acts on focus, and without digestion or blood system, medicine can seriously not diluted at the body foci position, treatment men and women sexually transmitted disease (STD) effect highly significant.
Claims (4)
1, a kind of external used medicine for the treatment of sexually transmitted disease (STD) is characterized in that it is the medicament of being made by following weight (part) proportion raw material:
Metronidazole 95-100 clotrimazole 20-25 chlorhexidine acetate 6-8
Fludrocortisone acetate 0.3-0.5 diethylstilbestrol 0.2-0.25 Borneolum Syntheticum 15-17
White vaseline 2700-3000
2, a kind of external used medicine for the treatment of sexually transmitted disease (STD) as claimed in claim 1 is characterized in that weight (part) proportioning of each raw material is:
Metronidazole 100 clotrimazoles 25 chlorhexidine acetates 7.5
Fludrocortisone acetate 0.5 diethylstilbestrol 0.25 Borneolum Syntheticum 17
White vaseline 3000
3, a kind of external used medicine for the treatment of sexually transmitted disease (STD) as claimed in claim 1 or 2 is characterized in that said medicament is capsule or cream.
4, a kind of preparation technology who treats the external used medicine of sexually transmitted disease (STD) as claimed in claim 3 is characterized in that its preparation technology is:
(1) mixes: take by weighing all medicines by composition weight (except the white vaseline), mix;
(2) pulverize: the hybrid medicine processing powder is broken into 100 order fineness;
(3) manufacture capsule: in the hybrid medicine after will pulverizing incapsulates;
(4) manufacture cream: hybrid medicine and white vaseline after will pulverizing are mixed and made into cream.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 00113827 CN1326737A (en) | 2000-06-02 | 2000-06-02 | External use medicine for curing sexual disease and its preparing process |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 00113827 CN1326737A (en) | 2000-06-02 | 2000-06-02 | External use medicine for curing sexual disease and its preparing process |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1326737A true CN1326737A (en) | 2001-12-19 |
Family
ID=4583578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 00113827 Pending CN1326737A (en) | 2000-06-02 | 2000-06-02 | External use medicine for curing sexual disease and its preparing process |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1326737A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101890003A (en) * | 2009-11-16 | 2010-11-24 | 江苏亚邦强生药业有限公司 | Method for preparing novel chlorhexidine acetate cream |
CN109602728A (en) * | 2019-01-18 | 2019-04-12 | 江苏福锌雨医药科技有限公司 | A kind of fludrocortisone acetate oral quick-dissolving film preparation and preparation method thereof |
CN112494497A (en) * | 2020-12-22 | 2021-03-16 | 唐凌文 | Compound liquid preparation and preparation method and application thereof |
-
2000
- 2000-06-02 CN CN 00113827 patent/CN1326737A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101890003A (en) * | 2009-11-16 | 2010-11-24 | 江苏亚邦强生药业有限公司 | Method for preparing novel chlorhexidine acetate cream |
CN109602728A (en) * | 2019-01-18 | 2019-04-12 | 江苏福锌雨医药科技有限公司 | A kind of fludrocortisone acetate oral quick-dissolving film preparation and preparation method thereof |
CN112494497A (en) * | 2020-12-22 | 2021-03-16 | 唐凌文 | Compound liquid preparation and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101874809A (en) | Local anti-inflammatory external medicinal composition using glycerol DMSO mixed solvent | |
CN1326737A (en) | External use medicine for curing sexual disease and its preparing process | |
CN1718211A (en) | Traditional Chinese emdicine compounding prepns. for treating fracture | |
CN1128633C (en) | Exterior-applied medicine for treating gynopathy | |
CN102648922B (en) | Gamuzhuer medicinal latex preparation and preparation method thereof | |
CN101700318A (en) | Ointment for treating hemorrhoids and preparation method thereof | |
CN1194665C (en) | Preparing method for superfine Chinese medicine jellies | |
CN1850100A (en) | Medicinal composition for treating vagina disease | |
CN114712376A (en) | Application of pulsatilla chinensis saponin B4 in preparation of external-use medicine for treating psoriasis | |
CN1939470A (en) | Chinese medicinal plaster with analgetic, hemostatic repercussive and sore-arresting functions | |
CN102349935A (en) | Purpose of ginkgolic acid in preparing external preparation for treating venereal disease, gynopathy and perianal disease | |
CN105362382A (en) | Traditional Chinese medicine composition for treating recurrent oral ulcer and application thereof | |
CN1602858A (en) | Arteannuin preparation for treating gynecopathy | |
CN105535939A (en) | Medicine composition for treating vaginitis and preparation method and application thereof | |
CN1283480A (en) | Medicine for treating piles | |
CN115025108B (en) | A pharmaceutical composition for treating pelvic inflammatory disease and preparation method thereof | |
CN104825740A (en) | Traditional Chinese medicine composition for treating skin burn | |
CN107050393A (en) | Numbness of relaxing dispersing paste and preparation method and application | |
CN115154528B (en) | A Chinese medicinal patch for external use for treating prostatitis and prostatic hyperplasia | |
CN106983822A (en) | It is a kind of to treat Chinese medicine composition of vaginitis and its preparation method and application | |
CN1229125C (en) | Medication for irregular menses and dysmenorrhea and preparation method | |
CN108354998B (en) | Extract for treating pelvic inflammation and preparation method thereof | |
CN1241571C (en) | Use of centella total glycoside in manufacture of medicine | |
CN101953851B (en) | Pills for treating pharyngitis, furuncle and carbuncle and ulcers and preparation method thereof | |
CN104055734A (en) | Traditional Chinese medicinal composition for treating vaginitis and preparation method of foam aerosol thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |